Business Wire07.18.17
Visioneering Technologies Inc. (VTI), a developer of products that redefine vision, has appointed Mark Rapoport as chief financial officer (CFO).
“Mark is an exceptionally accomplished financial leader, and we are excited to have a seasoned executive of his caliber on the VTI team,” said Stephen Snowdy, Ph.D., CEO of VTI. “He has a long and successful track record of strong financial management and contributing at the executive level to revenue and organizational growth.”
Rapoport brings more than three decades of experience in diverse industries, including healthcare technology. He has also served as the financial leader for several venture capital funded companies. As CFO, he will be responsible for overseeing the financial management of the company as it undergoes significant national and global sales and manufacturing expansions.
In his most recent position, Rapoport served as the CFO for Capsule Technologie SAS, a private equity-funded provider of medical device information system solutions acquired by Qualcomm Life Inc. Prior to that, Rapoport’s healthcare experience included president and CEO for Thomas, Thomas & Walsh Inc., a venture-capital-funded provider of Medicaid eligibility services to hospitals; and chief operating officer and CFO for Landacorp Inc. a publicly traded Nasdaq company providing medical management software solutions and technology-based disease management programs to hospitals and managed care organizations.
Rapoport earned his MBA in finance and accounting from Emory University in Atlanta, Ga., and his bachelor of arts degree in economics from State University of New York at Binghamton.
“I’m excited to be part of a team that is so passionate about bringing VTI’s revolutionary NaturalVue portfolio of contact lenses to market,” said Rapoport. “This is a dynamic and rapidly growing company and I look forward to using my skills to help VTI reach and exceed their goals.”
Visioneering Technologies Inc., headquartered in northern Atlanta, Ga., develops products that improve vision. With a portfolio of technologies, the company uses creative and differentiated design approaches to develop products that enhance practitioner and patient experiences. VTI optical designs have been awarded nine patents worldwide, with an additional 10 pending.
“Mark is an exceptionally accomplished financial leader, and we are excited to have a seasoned executive of his caliber on the VTI team,” said Stephen Snowdy, Ph.D., CEO of VTI. “He has a long and successful track record of strong financial management and contributing at the executive level to revenue and organizational growth.”
Rapoport brings more than three decades of experience in diverse industries, including healthcare technology. He has also served as the financial leader for several venture capital funded companies. As CFO, he will be responsible for overseeing the financial management of the company as it undergoes significant national and global sales and manufacturing expansions.
In his most recent position, Rapoport served as the CFO for Capsule Technologie SAS, a private equity-funded provider of medical device information system solutions acquired by Qualcomm Life Inc. Prior to that, Rapoport’s healthcare experience included president and CEO for Thomas, Thomas & Walsh Inc., a venture-capital-funded provider of Medicaid eligibility services to hospitals; and chief operating officer and CFO for Landacorp Inc. a publicly traded Nasdaq company providing medical management software solutions and technology-based disease management programs to hospitals and managed care organizations.
Rapoport earned his MBA in finance and accounting from Emory University in Atlanta, Ga., and his bachelor of arts degree in economics from State University of New York at Binghamton.
“I’m excited to be part of a team that is so passionate about bringing VTI’s revolutionary NaturalVue portfolio of contact lenses to market,” said Rapoport. “This is a dynamic and rapidly growing company and I look forward to using my skills to help VTI reach and exceed their goals.”
Visioneering Technologies Inc., headquartered in northern Atlanta, Ga., develops products that improve vision. With a portfolio of technologies, the company uses creative and differentiated design approaches to develop products that enhance practitioner and patient experiences. VTI optical designs have been awarded nine patents worldwide, with an additional 10 pending.
